litlas
ログインアカウント作成

Volkmar Müller

1991–2025 年に発表

別表記
Volkmar Muller
203
論文数
25,226
被引用数
81
h 指数
180
i10 指数

被引用数

Volkmar Müller の年別被引用数1971 年: 被引用 1 件1978 年: 被引用 1 件1982 年: 被引用 1 件1993 年: 被引用 2 件1995 年: 被引用 1 件1996 年: 被引用 5 件1997 年: 被引用 7 件1998 年: 被引用 11 件1999 年: 被引用 5 件2000 年: 被引用 11 件2001 年: 被引用 7 件2002 年: 被引用 5 件2003 年: 被引用 6 件2004 年: 被引用 6 件2005 年: 被引用 14 件2006 年: 被引用 12 件2007 年: 被引用 27 件2008 年: 被引用 60 件2009 年: 被引用 58 件2010 年: 被引用 63 件2011 年: 被引用 113 件2012 年: 被引用 170 件2013 年: 被引用 216 件2014 年: 被引用 225 件2015 年: 被引用 225 件2016 年: 被引用 344 件2017 年: 被引用 366 件2018 年: 被引用 393 件2019 年: 被引用 1,113 件2020 年: 被引用 1,326 件2021 年: 被引用 1,336 件2022 年: 被引用 1,038 件2023 年: 被引用 808 件2024 年: 被引用 1,200 件2025 年: 被引用 645 件2026 年: 被引用 29 件1972〜1977 年は被引用が無いため表示していません1979〜1981 年は被引用が無いため表示していません1983〜1992 年は被引用が無いため表示していません1994 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,668 件、この内訳の 20.1%中国: 引用元論文 1,955 件、この内訳の 14.7%ドイツ: 引用元論文 1,084 件、この内訳の 8.1%イタリア: 引用元論文 691 件、この内訳の 5.2%イギリス: 引用元論文 597 件、この内訳の 4.5%フランス: 引用元論文 486 件、この内訳の 3.7%スペイン: 引用元論文 442 件、この内訳の 3.3%日本: 引用元論文 371 件、この内訳の 2.8%オーストラリア: 引用元論文 346 件、この内訳の 2.6%カナダ: 引用元論文 334 件、この内訳の 2.5%スイス: 引用元論文 321 件、この内訳の 2.4%オランダ: 引用元論文 308 件、この内訳の 2.3%
0%20.1%その他 27.8%

機関

分野

  • Biochemistry, Genetics and Molecular Biology56.2%
  • Medicine36.8%
  • Immunology and Microbiology2.5%
  • Engineering2%
  • Computer Science0.6%
  • Materials Science0.5%
  • その他1.4%

トピック

  • Extracellular vesicles in disease10.8%
  • MicroRNA in disease regulation8.2%
  • Cancer Cells and Metastasis5.8%
  • Cancer Genomics and Diagnostics4.4%
  • Breast Cancer Treatment Studies3.9%
  • Circular RNAs in diseases3.2%
  • その他63.7%

共著者

全論文

検索で開く
  1. Tumour exosome integrins determine organotropic metastasis

    著者: Ayuko Hoshino, Bruno Costa‐Silva, Tang‐Long Shen, Gonçalo Rodrigues, Ayako Hashimoto, Milica Tešić Mark, Henrik Molina, Shinji Kohsaka, Angela Di Giannatale, Sophia Ceder, Swarnima Singh, Caitlin Williams, Nadine Soplop, Kunihiro Uryu, Lindsay A. Pharmer, Tari A. King, Linda Bojmar, Alexander E. Davies, Yonathan Ararso, Tuo Zhang, Haiying Zhang, Jonathan M. Hernandez, Joshua M. Weiss, Vanessa D Dumont-Cole, Kimberly Kramer, Leonard H. Wexler, Aru Narendran, Gary K. Schwartz, John H. Healey, Per Sandström, Knut Jørgen Labori, Elin H. Kure, Paul M. Grandgenett, Michael A. Hollingsworth, Maria de Sousa, Sukhwinder Kaur, Maneesh Jain, Kavita Mallya, Surinder K. Batra, William R. Jarnagin, Mary S. Brady, Øystein Fodstad, Volkmar Muller, Klaus Pantel, Andy J. Minn, Mina J. Bissell, Benjamin A. García, Yibin Kang, Vinagolu K. Rajasekhar, Cyrus M. Ghajar, Irina Matei, Héctor Peinado, Jacqueline Bromberg, David Lyden - Nature 2015 被引用: 5,185

  2. Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

    著者: Charles E. Geyer, Judy E. Garber, Richard D. Gelber, Greg Yothers, Manuel Taboada, L. Ross, Priya Rastogi, Karen Cui, Amal Arahmani, Gursel Aktan, Anne Armstrong, Mónica Arnedos, Judith Balmaña, Jonas Bergh, Judith M. Bliss, Suzette Delaloge, Susan M. Domchek, Andrea Eisen, F. Elsafy, L.E. Fein, Anitra Fielding, James M. Ford, Sue Friedman, Karen A. Gelmon, Luca Gianni, Michael Gnant, Simon J. Hollingsworth, Seock‐Ah Im, Agnes Jager, Oskar T. Johannsson, Sunil R. Lakhani, W Janni, Barbro Linderholm, T.-W. Liu, Niklas Loman, Larissa A. Korde, Sibylle Loibl, Peter C. Lucas, Frederik Marmé, E. Martinez de Dueñas, Robin McConnell, Kelly‐Anne Phillips, Martine Piccart, Giovanna Rossi, Rita K. Schmutzler, Elżbieta Senkus, Zhi-Ming Shao, Priyanka Sharma, Christian F. Singer, Tanja Španić, Elmar Stickeler, Masakazu Toi, Tiffany A. Traina, Giuseppe Viale, Gabriele Zoppoli, Y.H. Park, Rinat Yerushalmi, Huan Yang, D. Pang, Kyung Hae Jung, Audrey Mailliez, Zhaoqing Fan, Isabelle Tennevet, J. Zhang, T. Nagy, Gabe S. Sonke, Qiuhong Sun, Marina Parton, Marco Colleoni, Marcus Schmidt, Adam Brufsky, W. Razaq, Bella Kaufman, David Cameron, Christine Campbell, Andrew Tutt, P. Sevelda, Ferdinand Haslbauer, Monika Penzinger, Leopold Öhler, Christoph Tinchon, Richard Greil, Sonja Heibl, Rupert Bartsch, Viktor Wette, Christian F. Singer, Claudia Pasterk, Ruth Helfgott, Gunda Pristauz-Telsnigg, Herbert Stöger, A. Weltermann, Daniel Egle, I. Thiel, David Fuchs, Holger Rumpold, Kathrin Strasser‐Weippl, Beate Rautenberg, Volkmar Müller, Marcus Schmidt, Stefan Paepke ほか 509 名 - Annals of Oncology 2022 被引用: 447

  3. Intracranial Efficacy and Survival With Tucatinib Plus Trastuzumab and Capecitabine for Previously Treated HER2-Positive Breast Cancer With Brain Metastases in the HER2CLIMB Trial

    著者: Nancy U. Lin, Virginia F. Borges, Carey K. Anders, Rashmi K. Murthy, Elisavet Paplomata, Erika Hamilton, Sara A. Hurvitz, Sherene Loi, Alicia Okines, Vandana G. Abramson, Philippe L. Bédard, Mafalda Oliveira, Volkmar Müller, Amelia Zelnak, Michael P. DiGiovanna, Thomas Bachelot, A. Jo Chien, Ruth O’Regan, Andrew Wardley, Alison Conlin, David Cameron, Lisa A. Carey, Giuseppe Curigliano, Karen A. Gelmon, Sibylle Loibl, JoAl Mayor, Suzanne McGoldrick, Xuebei An, Eric P. Winer - Journal of Clinical Oncology 2020 被引用: 549

  4. Tucatinib vs Placebo, Both in Combination With Trastuzumab and Capecitabine, for Previously Treated ERBB2 (HER2)-Positive Metastatic Breast Cancer in Patients With Brain Metastases

    著者: Nancy U. Lin, Rashmi K. Murthy, Vandana G. Abramson, Carey K. Anders, Thomas Bachelot, Philippe L. Bédard, Virginia F. Borges, David Cameron, Lisa A. Carey, A. Jo Chien, Giuseppe Curigliano, Michael P. DiGiovanna, Karen A. Gelmon, Gabriel N. Hortobágyi, Sara A. Hurvitz, Ian E. Krop, Sherene Loi, Sibylle Loibl, Volkmar Müller, Mafalda Oliveira, Elisavet Paplomata, Mark D. Pegram, Dennis J. Slamon, Amelia Zelnak, Jorge Ramos, Wentao Feng, Eric P. Winer - JAMA Oncology 2022 被引用: 197

  5. Tucatinib versus placebo added to trastuzumab and capecitabine for patients with pretreated HER2+ metastatic breast cancer with and without brain metastases (HER2CLIMB): final overall survival analysis

    著者: Giuseppe Curigliano, Volkmar Müller, Virginia F. Borges, Erika Hamilton, Sara A. Hurvitz, Sherene Loi, Rashmi K. Murthy, Alicia Okines, E. Paplomata, David Cameron, Lisa A. Carey, Karen A. Gelmon, Gabriel N. Hortobágyi, Ian E. Krop, Sibylle Loibl, Mark D. Pegram, Dennis J. Slamon, Jorge Ramos, Wentao Feng, Eric P. Winer - Annals of Oncology 2021 被引用: 210

  6. Tumor mutational burden and immune infiltration as independent predictors of response to neoadjuvant immune checkpoint inhibition in early TNBC in GeparNuevo

    著者: Thomas Karn, Carsten Denkert, Karsten E. Weber, Uwe Holtrich, Claus Hanusch, Bruno V. Sinn, Brandon W. Higgs, Paul Jank, Hans‐Peter Sinn, Jens Huober, Christoph Becker, Jens‐Uwe Blohmer, Frederik Marmé, Wolfgang Schmitt, Song Wu, Marion van Mackelenbergh, Volkmar Müller, Christian Schem, Elmar Stickeler, Peter A. Fasching, Christian Jackisch, Michael Untch, Andreas Schneeweiß, Sibylle Loibl - Annals of Oncology 2020 被引用: 238

  7. 6th and 7th International consensus guidelines for the management of advanced breast cancer (ABC guidelines 6 and 7)

    著者: Fátima Cardoso, Shani Paluch–Shimon, Eva Schumacher-Wulf, Leonor Vasconcelos de Matos, Karen A. Gelmon, Matti Aapro, Jyoti Bajpai, Carlos H. Barrios, Jonas Bergh, Elizabeth Bergsten-Nordström, Laura Biganzoli, Maria João Cardoso, Lisa A. Carey, Mariana Chávez‐MacGregor, Runcie C.W. Chidebe, Javier Cortés, Giuseppe Curigliano, Rebecca Dent, Nagi S. El Saghir, Alexandru Eniu, Lesley Fallowfield, Prudence A. Francis, Sandra X. Franco Millan, Jenny Gilchrist, Joseph Gligorov, William J. Gradishar, Renate Haidinger, Nadia Harbeck, Xichun Hu, Ranjit Kaur, Belinda E. Kiely, Sungbae Kim, Smruti Koppikar, Marion Kuper‐Hommel, Frédéric Lecouvet, Ginny Mason, Shirley Mertz, Volkmar Müller, Claire Myerson, Silvia P. Neciosup, Birgitte Vrou Offersen, Shinji Ohno, Olivia Pagani, Ann H. Partridge, Frédérique Penault‐Llorca, Aleix Prat, Hope S. Rugo, Elżbieta Senkus, George W. Sledge, Sandra M. Swain, Christoph Thomssen, Daniel Vorobiof, Peter Vuylsteke, Theresa Wiseman, Binghe Xu, Alberto Costa, Larry Norton, Eric P. Winer - The Breast 2024 被引用: 197

  8. Detection of Circulating Tumor Cells in Peripheral Blood of Patients with Metastatic Breast Cancer: A Validation Study of the CellSearch System

    著者: Sabine Riethdorf, Herbert A. Fritsche, Volkmar Müller, Thomas Rau, Christian Schindlbeck, Brigitte Rack, Wolfgang Janni, Cornelia Coith, Katrin Beck, F. Jänicke, Summer Jackson, Terrie G. Gornet, Massimo Cristofanilli, Klaus Pantel - Clinical Cancer Research 2007 被引用: 1,337

  9. Circulating Tumor Cells in Breast Cancer Patients Treated by Neoadjuvant Chemotherapy: A Meta-analysis

    著者: François‐Clément Bidard, Stefan Michiels, Sabine Riethdorf, Volkmar Müller, Laura J. Esserman, Anthony Lucci, Bjørn Naume, Jun Horiguchi, Rafael Gisbert‐Criado, Stefan Sleijfer, Masakazu Toi, José Á. García-Sáenz, Andreas D. Hartkopf, Daniele Generali, Françoise Rothé, Jeffrey B. Smerage, Laura Muinelo‐Romay, Justin Stebbing, Patrice Viens, Mark Jesus M. Magbanua, Carolyn Hall, Olav Engebraaten, Daisuke Takata, José Vidal-Martínez, Wendy Onstenk, Noriyoshi Fujisawa, Eduardo Díaz‐Rubio, Florin‐Andrei Taran, Maria Rosa Cappelletti, Michail Ignatiadis, Charlotte Proudhon, Denise M. Wolf, Jessica B. Bauldry, Elin Borgen, Rin Nagaoka, Vicente Carañana, Jaco Kraan, Marisa Maestro, Sara Y. Brucker, Karsten E. Weber, Fabien Reyal, Dominic Amara, Mandar Karhade, Randi R. Mathiesen, H. Tokiniwa, Antonio Llombart‐Cussac, Alessandra Meddis, Paul Blanche, Koenraad D’Hollander, Paul Cottu, John W. Park, Sibylle Loibl, Aurélien Latouche, Jean‐Yves Pierga, Klaus Pantel - JNCI Journal of the National Cancer Institute 2018 被引用: 282

  10. Efficacy of Lapatinib in Patients with HER2-Negative Metastatic Breast Cancer and HER2-Positive Circulating Tumor Cells—The DETECT III Clinical Trial

    著者: Tanja Fehm, Volkmar Müller, Maggie Banys‐Paluchowski, Peter A. Fasching, Thomas W. P. Friedl, Andreas D. Hartkopf, Jens Huober, Christian R. Loehberg, Brigitte Rack, Sabine Riethdorf, Andreas Schneeweiß, D. Wallwiener, F Meier-Stiegen, Natalia Krawczyk, Bernadette Jaeger, F Reinhardt, Oliver Hoffmann, Lothar Mueller, Pauline Wimberger, Eugen Ruckhaeberle, Jens‐Uwe Blohmer, Jan‐Philipp Cieslik, André Franken, Dieter Niederacher, Hans Neubauer, Klaus Pantel, Wolfgang Janni, for the DETECT Study Group - Clinical Chemistry 2024 被引用: 69

  11. Trastuzumab deruxtecan in HER2-positive advanced breast cancer with or without brain metastases: a phase 3b/4 trial

    著者: Nadia Harbeck, Eva Ciruelos, Guy Jérusalem, Volkmar Müller, Naoki Niikura, Giuseppe Viale, Rupert Bartsch, Christian Kurzeder, Michaela J. Higgins, Roisín M. Connolly, Sally Baron‐Hay, María Gión, Valentina Guarneri, Giampaolo Bianchini, Hans Wildiers, Santiago Escrivá-de-Romaní, Manoj Prahladan, Helen Bridge, Nataliya Kuptsova‐Clarkson, Nana Scotto, Sunil Verma, Nancy U. Lin, the DESTINY-Breast12 study group, Belinda Yeo, Nicole McCarthy, Amelia McCartney, Timothy Clay, Nicholas Murray, Andrea Gombos, Joëlle Collignon, Eveline De Cuypere, Katarzyna Jerzak, Stephen Chia, Maja Maraldo, Jeanette Rønlev, Eva Brix, Minna Tanner, Johanna Mattson, Riikka Huovinen, Pauline Wimberger, Mattea Reinisch, Hans Tesch, Michael Untch, Peter Fasching, Tjoung-Won Park-Simon, Joke Tio, Michael Braun, Eva Maria Grischke, Frederik Marmé, Marion van Mackelenbergh, John McCaffrey, Michelino De Laurentiis, Michele Caruso, Rossana Berardi, Laura Biganzoli, Vittoria Fotia, Toshinari Yamashita, Junji Tsurutani, Koichiro Tsugawa, Nobumoto Tomioka, Maaike de Boer, Daniel Houtsma, Martin Pilskog, Olav Engebråten, Anna Sætersdal, Piotr Wysocki, Zbigniew Nowecki, Barbara Radecka, Jacek Jassem, Renata Duchnowska, Joana Simões, Fatima Cardoso, Ana Rita Sousa, María Jesús Vidal Losada, Cristina Saura Manich, Joaquin Gavilá Gregori, Maria Pilar Lopez Marti, Manuel Ruiz Borrego, Javier Cortés Castán, Rafael López López, César Rodríguez Sanchez, Encarnación González Flores, Carmen Hinojo González, Purificación Martínez del Prado, Aglaia Schiza, Fredrika Killander, Leif Klint, Lorenzo Rossi, Stefan Aebi, Khalil Zaman, Peter Hall, Carey Anders - Nature Medicine 2024 被引用: 183

  12. Presence of Circulating Tumor Cells in High-Risk Early Breast Cancer During Follow-Up and Prognosis

    著者: Elisabeth Trapp, Wolfgang Janni, Christian Schindlbeck, Julia Jückstöck, Ulrich Andergassen, Amelie de Gregorio, Marianna Alunni‐Fabbroni, Marie Tzschaschel, Arkadius Polasik, Julian Koch, Thomas W. P. Friedl, Peter A. Fasching, Lothar Haeberle, Tanja Fehm, Andreas Schneeweiß, Matthias W. Beckmann, Klaus Pantel, Volkmar Müller, Brigitte Rack, Christoph Scholz, SUCCESS Study Group - JNCI Journal of the National Cancer Institute 2018 被引用: 138

  13. Germline Mutation Status, Pathological Complete Response, and Disease-Free Survival in Triple-Negative Breast Cancer

    著者: Eric Hahnen, Bianca Lederer, Jan Hauke, Sibylle Loibl, Sandra Kröber, Andreas Schneeweiß, Carsten Denkert, Peter A. Fasching, Jens‐Uwe Blohmer, Christian Jackisch, Stefan Paepke, Bernd Gerber, Sherko Kümmel, Christian Schem, Guido Neidhardt, Jens Huober, Kerstin Rhiem, Serban Dan Costa, Janine Altmüller, Claus Hanusch, Hölger Thiele, Volkmar Müller, Peter Nürnberg, Thomas Karn, Valentina Nekljudova, Michael Untch, Gϋnter von Minckwitz, Rita K. Schmutzler - JAMA Oncology 2017 被引用: 394

  14. Breast cancer brain metastases: biology and new clinical perspectives

    著者: Isabell Witzel, Leticia Oliveira‐Ferrer, Klaus Pantel, Volkmar Müller, Harriet Wikman - Breast Cancer Research 2016 被引用: 304

  15. A New Molecular Predictor of Distant Recurrence in ER-Positive, HER2-Negative Breast Cancer Adds Independent Information to Conventional Clinical Risk Factors

    著者: Martin Filipits, Margaretha Rudas, R. Jakesz, Peter Dubsky, Florian Fitzal, Christian F. Singer, Otto Dietze, Richard Greil, Andrea Jelen, P. Sevelda, Christa Freibauer, Volkmar Müller, F. Jänicke, Marcus Schmidt, H. Kölbl, Achim Rody, Manfred Kaufmann, Werner Schroth, Hiltrud Brauch, Matthias Schwab, Péter Fritz, Karsten E. Weber, Inke Sabine Feder, Guido Hennig, Ralf Kronenwett, Mathias Gehrmann, Michael Gnant - Clinical Cancer Research 2011 被引用: 728

  16. Diagnostic and prognostic relevance of circulating exosomal miR-373, miR-200a, miR-200b and miR-200c in patients with epithelial ovarian cancer

    著者: Xiaodan Meng, Volkmar Müller, Karin Milde‐Langosch, Fabian Trillsch, Klaus Pantel, Heidi Schwarzenbach - Oncotarget 2016 被引用: 267

  17. Specific microRNA signatures in exosomes of triple-negative and HER2-positive breast cancer patients undergoing neoadjuvant therapy within the GeparSixto trial

    著者: Ines Stevic, Volkmar Müller, Karsten E. Weber, Peter A. Fasching, Thomas Karn, Frederic Marmé, Christian Schem, Elmar Stickeler, Carsten Denkert, Marion van Mackelenbergh, Christoph Salat, Andreas Schneeweiß, Klaus Pantel, Sibylle Loibl, Michael Untch, Heidi Schwarzenbach - BMC Medicine 2018 被引用: 207

  18. A novel microfluidic platform for size and deformability based separation and the subsequent molecular characterization of viable circulating tumor cells

    著者: G.E. Hvichia, Zahida Parveen, Cosima Wagner, Melanie Janning, Julia Quidde, Alex Stein, Volkmar Müller, Sonja Loges, Rui P. Neves, Nikolas H. Stoecklein, Harriet Wikman, Sabine Riethdorf, Klaus Pantel, Tobias M. Gorges - International Journal of Cancer 2016 被引用: 191

  19. Increased serum levels of circulating exosomal microRNA-373 in receptor-negative breast cancer patients

    著者: Corinna Eichelser, Isabel Stückrath, Volkmar Müller, Karin Milde‐Langosch, Harriet Wikman, Klaus Pantel, Heidi Schwarzenbach - Oncotarget 2014 被引用: 376

  20. Preference for subcutaneous or intravenous administration of trastuzumab in patients with HER2-positive early breast cancer (PrefHer): an open-label randomised study

    著者: Xavier Pivot, Joseph Gligorov, Volkmar Müller, Peter Barrett‐Lee, Sunil Verma, Ann Knoop, Giuseppe Curigliano, Semiglazov Vf, Guillermo López-Vivanco, Valerie Jenkins, Nana Scotto, Stuart Osborne, Lesley Fallowfield - The Lancet Oncology 2013 被引用: 226

  21. Exosomal microRNAs as tumor markers in epithelial ovarian cancer

    著者: Chi Pan, Ines Stevic, Volkmar Müller, Qingtao Ni, Leticia Oliveira‐Ferrer, Klaus Pantel, Heidi Schwarzenbach - Molecular Oncology 2018 被引用: 184

  22. Characterization of circulating breast cancer cells with tumorigenic and metastatic capacity

    著者: Claudia Koch, Andra Kuske, Simon A. Joosse, Gökhan Yigit, George Sflomos, Sonja Thaler, Daniel J. Smit, Stefan Werner, Kerstin Borgmann, Sebastian Gärtner, Parinaz Mossahebi Mohammadi, Laura Battista, Laure Cayrefourcq, Janine Altmüller, Gabriela Salinas-Riester, Kaamini Raithatha, Arne Zibat, Y. Goy, Leonie Ott, Kai Bartkowiak, Tuan Zea Tan, Qing Zhou, Michael R. Speicher, Volkmar Müller, Tobias M. Gorges, Manfred Jücker, Jean Paul Thiery, Cathrin Brisken, Sabine Riethdorf, Catherine Alix‐Panabières, Klaus Pantel - EMBO Molecular Medicine 2020 被引用: 117

  23. Prognostic Impact of Circulating Tumor Cells for Breast Cancer Patients Treated in the Neoadjuvant "Geparquattro" Trial

    著者: Sabine Riethdorf, Volkmar Müller, Sibylle Loibl, Valentina Nekljudova, Karsten Weber, Jens Huober, Tanja Fehm, Iris Schrader, J. Hilfrich, Frank Holms, Hans Tesch, Christian Schem, Gϋnter von Minckwitz, Michael Untch, Klaus Pantel - Clinical Cancer Research 2017 被引用: 114

  24. Prognostic relevance of the HER2 status of circulating tumor cells in metastatic breast cancer patients screened for participation in the DETECT study program

    著者: Volkmar Müller, Maggie Banys‐Paluchowski, Thomas W. P. Friedl, Peter A. Fasching, Andreas Schneeweiß, Andreas D. Hartkopf, D. Wallwiener, Brigitte Rack, F Meier-Stiegen, Jens Huober, Matthias Rübner, Oliver Hoffmann, L. Müller, Wolfgang Janni, Pauline Wimberger, Bernadette Jäger, Klaus Pantel, Sabine Riethdorf, Nadia Harbeck, Tanja Fehm - ESMO Open 2021 被引用: 53